Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04184648Completed

Comparison of Classification Standards of Bronchopulmonary Dysplasia (BPD) in Premature Infants

Role: lead

NCT05865977Recruiting

dTDI During a SBT to Predict Extubation Failure in Preterm Infants

Role: lead

NCT04163822Completed

Analysis of BPD in Premature Infants With Typical Imaging Changes

Role: lead

NCT04237844Unknown

Clinic Features and Outcome of BPD (SGBPD)

Role: lead

All 4 trials loaded